Literature DB >> 16634796

Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene.

N Martinez-Pomar1, S Raga, J Ferrer, J Pons, I Munoz-Saa, M-R Julia, J de Gracia, N Matamoros.   

Abstract

Common variable immunodeficiency disease (CVID) is a heterogeneous syndrome characterized by low immunoglobulin serum levels and recurrent bacterial infections. Several studies suggest that CVID patients have a polarized immune response towards a T helper type 1 phenotype (TH1). However, the factors causing the TH1 polarization remain to be determined in this disease. In the present study, serum interleukin (IL)-12, interferon (IFN)-gamma levels and the IL-12p40 and IFN-gamma gene were studied in CVID patients. Furthermore, we evaluate dendritic cells (DCs) compartment, myeloid dendritic cells (mDCs) and plasmocytoid dendritic cells (pDCs), which help to differentiate naive T cells preferentially into TH1 and TH2, respectively. The serum IL-12p40 subunit levels were increased significantly in CVID patients compared to healthy controls. We examined whether these elevated serum IL-12p40 levels are associated with IFN-gamma or IL-12p40 gene polymorphisms, or with new mutations in the IL-12p40 promoter gene. In our hands, no new mutations were found and gene polymorphisms frequencies in CVID patients were similar to the control population. In conclusion, the elevated serum levels of IL-12p40 found in our CVID patients were not related to these genetic variations. The DC compartment analysis did not show an imbalance between pDCs and mDCs, but revealed the presence of low numbers and percentage of both DC populations in CVID.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16634796      PMCID: PMC1809649          DOI: 10.1111/j.1365-2249.2006.03063.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency.

Authors:  R Cambronero; W A Sewell; M E North; A D Webster; J Farrant
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  Absence of memory B cells in patients with common variable immunodeficiency.

Authors:  Kazunaga Agematsu; Takeshi Futatani; Sho Hokibara; Norimoto Kobayashi; Masaya Takamoto; Satoshi Tsukada; Harumi Suzuki; Shigeo Koyasu; Toshio Miyawaki; Kazuo Sugane; Atsushi Komiyama; Hans D Ochs
Journal:  Clin Immunol       Date:  2002-04       Impact factor: 3.969

3.  Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells.

Authors:  S F Wolf; P A Temple; M Kobayashi; D Young; M Dicig; L Lowe; R Dzialo; L Fitz; C Ferenz; R M Hewick
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

4.  Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor.

Authors:  U Gubler; A O Chua; D S Schoenhaut; C M Dwyer; W McComas; R Motyka; N Nabavi; A G Wolitzky; P M Quinn; P C Familletti
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

5.  Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells.

Authors:  A S Stern; F J Podlaski; J D Hulmes; Y C Pan; P M Quinn; A G Wolitzky; P C Familletti; D L Stremlo; T Truitt; R Chizzonite
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Modulating effects of intravenous immunoglobulins on serum cytokine levels in patients with primary hypogammaglobulinemia.

Authors:  Cristina Ibáñez; Pilar Suñé; Ana Fierro; Santiago Rodríguez; Maite López; Antonio Alvarez; Javier De Gracia; José-Bruno Montoro
Journal:  BioDrugs       Date:  2005       Impact factor: 5.807

7.  Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children.

Authors:  Grant Morahan; Dexing Huang; Mark Wu; Barbara J Holt; Gregory P White; Garth E Kendall; Peter D Sly; Patrick G Holt
Journal:  Lancet       Date:  2002-08-10       Impact factor: 79.321

8.  Common variable immunodeficiency is associated with defective functions of dendritic cells.

Authors:  Jagadeesh Bayry; Sébastien Lacroix-Desmazes; Michel D Kazatchkine; Lionel Galicier; Yves Lepelletier; David Webster; Yves Lévy; Martha M Eibl; Eric Oksenhendler; Olivier Hermine; Srini V Kaveri
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

9.  Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.

Authors:  B Piqueras; C Lavenu-Bombled; L Galicier; F Bergeron-van der Cruyssen; L Mouthon; S Chevret; P Debré; C Schmitt; E Oksenhendler
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

10.  Evidence for increased expression of regulatory cytokine receptors interleukin-12R and interleukin-18R in common variable immunodeficiency.

Authors:  A McQuaid; V J Tormey; B Trafford; A D Webster; M Bofill
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

View more
  14 in total

1.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

Review 2.  Common variable immune deficiency: Dissection of the variable.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

3.  Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9.

Authors:  E Taraldsrud; B Fevang; P Aukrust; K H Beiske; Y Fløisand; S Frøland; H Rollag; J Olweus
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

Review 4.  Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions.

Authors:  Helen Chapel; Charlotte Cunningham-Rundles
Journal:  Br J Haematol       Date:  2009-03-30       Impact factor: 6.998

5.  Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels.

Authors:  R R Barbosa; S P Silva; S L Silva; R Tendeiro; A C Melo; E Pedro; M P Barbosa; M C P Santos; R M M Victorino; A E Sousa
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

6.  Altered serum cytokine signature in common variable immunodeficiency.

Authors:  Zdenek Hel; Richard P H Huijbregts; Jun Xu; Jana Nechvatalova; Marcela Vlkova; Jiri Litzman
Journal:  J Clin Immunol       Date:  2014-09-23       Impact factor: 8.317

Review 7.  Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.

Authors:  Farnaz Najmi Varzaneh; Bärbel Keller; Susanne Unger; Asghar Aghamohammadi; Klaus Warnatz; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05-15       Impact factor: 8.317

8.  Intracellular overexpression of HIV-1 Nef impairs differentiation and maturation of monocytic precursors towards dendritic cells.

Authors:  Yan Guo; Wen-Wen Xu; Jie Song; Wen Deng; Di-Qiu Liu; Hua-Tang Zhang
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

Review 9.  State-of-the-art diagnostic evaluation of common variable immunodeficiency.

Authors:  Theodore K Lee; Jessica D Gereige; Paul J Maglione
Journal:  Ann Allergy Asthma Immunol       Date:  2021-03-11       Impact factor: 6.248

10.  Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications.

Authors:  Miranda L Abyazi; Kayla A Bell; Gavin Gyimesi; Turner S Baker; Minji Byun; Huaibin M Ko; Charlotte Cunningham-Rundles; Feng Feng; Paul J Maglione
Journal:  J Allergy Clin Immunol       Date:  2021-06-17       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.